Christopher E M Griffiths Selected Research

Christopher E M Griffiths Research Topics

Disease

107	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2022 - 01/2002
8	Neoplasms (Cancer) 06/2022 - 08/2006
8	Infections 01/2021 - 08/2006
7	Inflammation (Inflammations) 12/2022 - 08/2006
6	Necrosis 02/2015 - 10/2005
5	Psoriatic Arthritis 10/2022 - 06/2011
4	Atopic Dermatitis (Atopic Eczema) 10/2022 - 09/2008
4	Skin Neoplasms (Skin Cancer) 02/2020 - 11/2002
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2022 - 02/2020
3	Crohn Disease (Crohn's Disease) 02/2020 - 11/2005
3	Systemic Scleroderma (Systemic Sclerosis) 09/2016 - 08/2012
3	Rheumatoid Arthritis 05/2015 - 06/2005
3	Skin Diseases (Skin Disease) 02/2014 - 02/2004
3	Autoimmune Diseases (Autoimmune Disease) 04/2013 - 06/2005
2	COVID-19 10/2021 - 01/2021
2	Arthritis (Polyarthritis) 01/2021 - 02/2014
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021 - 01/2019
2	Injection Site Reaction 01/2019 - 10/2017
2	Eczema 10/2017 - 08/2004
2	Telangiectasis (Telangiectasia) 08/2014 - 03/2013
1	Cytopenia 06/2022
1	Body Weight (Weight, Body) 05/2022
1	Obesity 01/2021
1	Dementia (Dementias) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Streptococcal Infections (Streptococcal Infection) 01/2021
1	Ulcerative Colitis 02/2020
1	Rare Diseases (Rare Disease) 08/2018
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2018
1	Asthma (Bronchial Asthma) 10/2017
1	Conjunctivitis 10/2017

Drug/Important Bio-Agent (IBA)

18	Biological ProductsIBA 10/2022 - 06/2004
15	Ustekinumab (CNTO 1275)FDA Link 10/2022 - 01/2010
14	Pharmaceutical PreparationsIBA 10/2022 - 09/2007
13	Adalimumab (Humira)FDA Link 10/2022 - 05/2015
12	Etanercept (Enbrel)FDA Link 05/2022 - 01/2010
11	ixekizumabIBA 10/2022 - 08/2015
10	Monoclonal AntibodiesIBA 11/2020 - 06/2004
9	Interleukin-17 (Interleukin 17)IBA 01/2022 - 07/2014
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021 - 07/2004
8	InterleukinsIBA 08/2021 - 05/2012
7	guselkumabIBA 10/2022 - 03/2017
7	CytokinesIBA 01/2021 - 07/2004
6	secukinumabIBA 10/2022 - 07/2014
6	Immunoglobulin A (IgA)IBA 05/2022 - 10/2017
6	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 08/2008
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
6	Interleukin-23 (Interleukin 23)IBA 01/2021 - 01/2010
6	Infliximab (Remicade)FDA Link 01/2010 - 10/2005
5	Proteins (Proteins, Gene)FDA Link 11/2017 - 06/2007
4	Immunologic Factors (Immunomodulators)IBA 10/2022 - 05/2008
4	AntibodiesIBA 11/2020 - 02/2014
4	RetinoidsIBA 01/2016 - 07/2003
3	omega-Chloroacetophenone (Mace)IBA 06/2022 - 03/2012
3	apremilastIBA 01/2022 - 07/2015
3	HLA-C Antigens (HLA-C)IBA 01/2021 - 11/2010
3	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 11/2020 - 08/2018
3	Interleukin-12 (IL 12)IBA 01/2019 - 01/2010
3	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 03/2013 - 06/2002
2	Immunomodulating AgentsIBA 10/2021 - 02/2004
2	Tumor Necrosis Factor InhibitorsIBA 10/2021 - 01/2019
2	GoldIBA 01/2021 - 08/2011
2	bimekizumabIBA 11/2020 - 08/2018
2	Prostaglandins AIBA 11/2020 - 01/2018
2	levocetirizine FDA LinkGeneric 01/2020 - 01/2020
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2018 - 09/2008
2	Interleukin-13IBA 10/2017 - 06/2011
2	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2016 - 07/2015
2	Anthralin (Dithranol)IBA 08/2015 - 01/2005
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 05/2014 - 02/2006
2	ProlactinIBA 01/2013 - 03/2012
2	Immunoglobulin G (IgG)IBA 09/2008 - 06/2007
2	AutoantibodiesIBA 09/2008 - 06/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2006 - 01/2004
1	Fibronectins (Fibronectin)IBA 12/2022
1	FibrillinsIBA 12/2022
1	Vitamin A (Retinol)FDA LinkGeneric 12/2022
1	ElastinIBA 12/2022
1	CollagenIBA 12/2022
1	RNA (Ribonucleic Acid)IBA 10/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Blocking AntibodiesIBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Interleukin-23 Subunit p19IBA 08/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	Histamine Antagonists (Antihistamines)IBA 01/2020
1	Histamine H1 Receptors (Histamine H1 Receptor)IBA 01/2020
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2020
1	Interleukin-1 (Interleukin 1)IBA 08/2018
1	LipidsIBA 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2017
1	Interleukin-4 (Interleukin 4)IBA 10/2017
1	dupilumabIBA 10/2017

Therapy/Procedure

39	Therapeutics 01/2021 - 06/2003
21	Biological Therapy 10/2022 - 04/2006
3	Photochemotherapy (Photodynamic Therapy) 01/2017 - 06/2003
2	Subcutaneous Injections 08/2018 - 01/2010
2	Phototherapy (Light Therapy) 01/2017 - 01/2016
2	Lasers (Laser) 09/2016 - 08/2014
2	Immunotherapy 01/2014 - 01/2002